223 related articles for article (PubMed ID: 33377904)
1. Trends in Industry Payments to Medical Oncologists in the United States Since the Inception of the Open Payments Program, 2014 to 2019.
Tarras ES; Marshall DC; Rosenzweig K; Korenstein D; Chimonas S
JAMA Oncol; 2021 Mar; 7(3):440-444. PubMed ID: 33377904
[TBL] [Abstract][Full Text] [Related]
2. Trends in Financial Relationships Between Industry and Radiation Oncologists Versus Other Physicians in the United States from 2014 to 2018.
Marshall DC; Tarras ES; Rosenzweig K; Yom SS; Hattangadi-Gluth J; Murphy J; Korenstein D; Chimonas S
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):15-25. PubMed ID: 32858112
[TBL] [Abstract][Full Text] [Related]
3. Types and Distribution of Payments From Industry to Physicians in 2015.
Tringale KR; Marshall D; Mackey TK; Connor M; Murphy JD; Hattangadi-Gluth JA
JAMA; 2017 May; 317(17):1774-1784. PubMed ID: 28464140
[TBL] [Abstract][Full Text] [Related]
4. Distribution and Patterns of Industry-Related Payments to Oncologists in 2014.
Marshall DC; Moy B; Jackson ME; Mackey TK; Hattangadi-Gluth JA
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27389914
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology.
Mitchell AP; Winn AN; Lund JL; Dusetzina SB
Oncologist; 2019 May; 24(5):632-639. PubMed ID: 30728276
[TBL] [Abstract][Full Text] [Related]
6. Increasing Financial Payments From Industry to Medical Oncologists in the United States, 2014-2017.
Rahman MW; Trivedi NU; Bach PB; Mitchell AP
J Natl Compr Canc Netw; 2021 Dec; 20(13):1-9. PubMed ID: 34965511
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Sex Distribution of Industry Payments Among Radiation Oncologists.
Weng JK; Valle LF; Nam GE; Chu FI; Steinberg ML; Raldow AC
JAMA Netw Open; 2019 Jan; 2(1):e187377. PubMed ID: 30681710
[TBL] [Abstract][Full Text] [Related]
8. Industry payments to US physicians for cancer therapeutics: An analysis of the 2016-2018 open payments datasets.
Meyers DE; Chisamore TM; McInnes MDF; Gyawali B; Prasad V; Booth CM
J Cancer Policy; 2021 Jun; 28():100283. PubMed ID: 35559912
[TBL] [Abstract][Full Text] [Related]
9. Examination of Industry Payments to Radiation Oncologists in 2014 Using the Centers for Medicare and Medicaid Services Open Payments Database.
Jairam V; Yu JB
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):19-26. PubMed ID: 26547386
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis.
Ozaki A; Saito H; Onoue Y; Sawano T; Shimada Y; Somekawa Y; Tsuji A; Tanimoto T
BMJ Open; 2019 Sep; 9(9):e028805. PubMed ID: 31494604
[TBL] [Abstract][Full Text] [Related]
11. A 9-Year Investigation of Healthcare Industry Payments to Pulmonologists in the United States.
Murayama A; Kugo H; Saito Y; Saito H; Tanimoto T; Ozaki A
Ann Am Thorac Soc; 2023 Sep; 20(9):1283-1292. PubMed ID: 36961514
[No Abstract] [Full Text] [Related]
12. Research and Nonresearch Industry Payments to Nephrologists in the United States between 2014 and 2021.
Murayama A; Kamamoto S; Kugo H; Saito H; Ozaki A
J Am Soc Nephrol; 2023 Oct; 34(10):1709-1720. PubMed ID: 37488676
[TBL] [Abstract][Full Text] [Related]
13. Industry Relationships With Medical Oncologists: Who Are the High-Payment Physicians?
Wright K; Meyers DE; Chisamore TM; McInnes MDF; Sismondo S; Gyawali B; Prasad V; Booth CM
JCO Oncol Pract; 2022 Jul; 18(7):e1164-e1169. PubMed ID: 35696634
[TBL] [Abstract][Full Text] [Related]
14. Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.
Mitchell AP; Mishra A; Dey P; Curry MA; Trivedi NU; Haddadin M; Rahman MW; Winn AN; Dusetzina SB; Bach PB
Oncologist; 2021 Sep; 26(9):771-778. PubMed ID: 33982829
[TBL] [Abstract][Full Text] [Related]
15. Nine-Year Analysis of Industry Payments to Geriatricians in the United States Between 2014 and 2022.
Murayama A
J Am Med Dir Assoc; 2023 Oct; ():104840. PubMed ID: 37918817
[TBL] [Abstract][Full Text] [Related]
16. Industry Payments to Practicing US Rheumatologists, 2014-2019.
Putman MS; Goldsher JE; Crowson CS; Duarte-García A
Arthritis Rheumatol; 2021 Nov; 73(11):2138-2144. PubMed ID: 34164951
[TBL] [Abstract][Full Text] [Related]
17. Trends in Industry Payments to Physicians in the First 6 Years After Graduate Medical Training.
Han M; Hogan SO; Holmboe E; Jing Y; Yamazaki K; Trock BJ
JAMA Netw Open; 2022 Oct; 5(10):e2237574. PubMed ID: 36260332
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Industry Payments to US Advanced Practice Clinicians in 2021.
Singh A; Hyman MJ; Modi PK
JAMA Netw Open; 2022 Nov; 5(11):e2242869. PubMed ID: 36399340
[TBL] [Abstract][Full Text] [Related]
19. Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018.
Nalleballe K; Sheng S; Li C; Mahashabde R; Annapureddy AR; Mudassar K; Pothineni K; Veerapaneni P; Harada Y; Chilkulwar A; Ranabothu S; Brown A; Kapoor N; Onteddu S
Stroke; 2020 Apr; 51(4):1339-1343. PubMed ID: 32078482
[TBL] [Abstract][Full Text] [Related]
20. Association between physician characteristics and payments from industry in 2015-2017: observational study.
Inoue K; Blumenthal DM; Elashoff D; Tsugawa Y
BMJ Open; 2019 Sep; 9(9):e031010. PubMed ID: 31542759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
